comparemela.com

Page 24 - Hans Vitzthum News Today : Breaking News, Live Updates & Top Stories | Vimarsana

ProQR to Present at the Retinal Cell and Gene Therapy Innovation Summit and the Association for Research in Vision and Ophthalmology (ARVO) 2022

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

University of pennsylvaniaUnited statesSarah kielyBart leroyStephenr russellMelita kaltakHans vitzthumRobert stanislaroArtur cideciyanHead of the ophthalmology departmentGhent university hospitalMeeting of the association for researchIowa universityExchange commissionOphthalmic genetics at ghent universityEuropean union

Actinium Pharmaceuticals, Inc to Highlight Iomab-B Pivotal Phase 3 SIERRA Trial Data at the Transplantation & Cellular Therapy Tandem Meetings of ASTCT and CIBMTR

- Updated Phase 3 SIERRA data to be presented in an oral presentation by Boglarka Gyurkocza, M.D., SIERRA trial investigator from Memorial Sloan Kettering.

United statesSalt lake citySalt palace convention centerHans vitzthumBoglarka gyurkoczaSandesh sethJames foranAvinash desaiLifesci advisorsUniversity of texas md anderson cancer centerAmerican society for transplantationInternational blood marrow transplant researchExchange commissionAstellas pharma incActinium pharmaceuticals incEuropean medicines agency

Acer Therapeutics and Relief Therapeutics Announce Presentation of ACER-001 Data at the Society for

Relief Therapeutics Holding SA / Key word(s): Study results12-Apr-2022 / 07:00 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss ExchangeAcer Therapeutics and Relief Therape.

United statesJim denikeMichael millerHans vitzthumRaghuram ram selvarajuJack weinsteinAdvita lifescience gmbRelief therapeutics holding sa keySociety for inherited metabolic disordersPharma researchDrug administrationSwiss exchangeRx communications groupExchange commissionEuropean medicines agencyRelief therapeutics holding

Acer Therapeutics and Relief Therapeutics Announce Presentation of ACER-001 Data at the Society for Inherited Metabolic Disorders Annual Meeting

Press release content from Accesswire. The AP news staff was not involved in its creation.

United statesJim denikeMichael millerHans vitzthumRaghuram ram selvarajuJack weinsteinAdvita lifescience gmbSociety for inherited metabolic disordersPharma researchDrug administrationSwiss exchangeRx communications groupExchange commissionRelief therapeutics holdingsEuropean medicines agencyRelief therapeutics holding

EQS-Adhoc: Relief Therapeutics Holding SA: Acer Therapeutics and Relief Therapeutics Announce Presentation of ACER-001 Data at the Society for Inherited Metabolic Disorders Annual Meeting

Relief Therapeutics Holding SA / Key word(s): Study results Acer Therapeutics and Relief Therapeutics Announce Presentation of ACER-001 Data at the Society for Inherited Metabolic Disorders Annual

United statesSwitzerland generalJim denikeMichael millerHans vitzthumRaghuram ram selvarajuJack weinsteinAdvita lifescience gmbRelief therapeutics holding sa keySociety for inherited metabolic disordersPharma researchDrug administrationSwiss exchangeRx communications groupExchange commissionEuropean medicines agency

vimarsana © 2020. All Rights Reserved.